NCT02641249

Brief Summary

Purpose of Study: Apnea of Prematurity (AOP) is common, affecting the majority of infants born \<34 weeks gestational age (GA). Apnea is accompanied by intermittent hypoxia (IH), which contributes to multiple pathologies, including retinopathy of prematurity (ROP), sympathetic ganglia injury, impaired pancreatic islet cell and bone development, and neurodevelopmental disabilities. Standard of care for AOP/IH includes prone positioning, positive pressure ventilation, and caffeine therapy, none of which is optimal. The objective is to support breathing in premature infants by using a simple, non-invasive vibratory device placed over limb proprioceptor fibers, an intervention using the principle that limb movements facilitate breathing. Methods Used: Premature infants (23-34 wks GA) with clinical evidence of AOP/IH were enrolled 1 week after birth. Caffeine therapy was not a reason for exclusion. Small vibration devices were placed on one hand and one foot and activated in a 6 hour ON/OFF sequence for a total of 24 hours. Heart rate, respiratory rate, oxygen saturation (SpO2), and breathing pauses were continuously collected.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
19

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2014

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2014

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2015

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

December 18, 2015

Completed
11 days until next milestone

First Posted

Study publicly available on registry

December 29, 2015

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2016

Completed
1.3 years until next milestone

Results Posted

Study results publicly available

May 9, 2017

Completed
Last Updated

May 9, 2017

Status Verified

November 1, 2016

Enrollment Period

10 months

First QC Date

December 18, 2015

Results QC Date

November 14, 2016

Last Update Submit

March 29, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in Total Number of Episodes of Apnea/Breathing Pauses During Intervention and Without Intervention

    The total number of apneas/breathing pauses will be compared during periods of vibration (intervention) to periods of no vibrations (no intervention).

    12 hours of intervention/12 hours of no intervention

Secondary Outcomes (2)

  • Change in the Total Number of Intermittent Hypoxic Episodes to <90% Lasting >5 Seconds/Episode During the Intervention and Without Intervention

    12 hours of intervention/12 hours of no intervention

  • Change in the Total Number of Bradycardia Episodes (<100 Beats Per Minute (Bpm), at Least 5 Seconds Long) During Intervention and Without the Intervention

    12 hours of intervention/12 hours of no intervention

Study Arms (2)

No vibration

NO INTERVENTION

In the same subject cardiorespiratory parameters - heart rate, respiratory rate and oxygen saturation were compared during the procedure (vibration) and without procedure (no vibration). The same subject had both control and treatment periods.

Vibration

EXPERIMENTAL

In the same subject cardiorespiratory parameters - heart rate, respiratory rate and oxygen saturation were compared during the procedure (vibration) and without procedure (no vibration). The same subject had both control and treatment periods.

Device: Vibration

Interventions

VibrationDEVICE

A device providing vibrations is placed on the subject and vibration is turned on and off in a 6 hour on/off sequence. Heart rate, respiratory pauses and oxygen saturation are compared during vibration (intervention) and without vibration (no intervention) in the same subject.

Also known as: (no generic name)
Vibration

Eligibility Criteria

Age1 Week+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Gestational age \> 23 weeks, \< 34 weeks
  • At least 1 week old at recruitment
  • Diagnosis of apnea of prematurity (AOP)

You may not qualify if:

  • Infants with major congenital anomalies/malformations which will influence central nervous system and long-term outcomes in these infants, such as cardiac anomalies (except for Patent Ductus Arteriosus or Ventricular Septal Defect) or major neurological malformations, like meningoencephalocele, holoprosencephaly etc.
  • Neonates who have apnea from airway issues like laryngomalacia or tracheomalacia
  • Neonates with history of hypoxic ischemic encephalopathy or Grade IV intraventricular hemorrhage

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Ronald Reagan Medical Center - UCLA

Los Angeles, California, 90095, United States

Location

Santa Monica UCLA Mecial Center

Santa Monica, California, 90404, United States

Location

Related Publications (1)

  • Kesavan K, Frank P, Cordero DM, Benharash P, Harper RM. Neuromodulation of Limb Proprioceptive Afferents Decreases Apnea of Prematurity and Accompanying Intermittent Hypoxia and Bradycardia. PLoS One. 2016 Jun 15;11(6):e0157349. doi: 10.1371/journal.pone.0157349. eCollection 2016.

MeSH Terms

Conditions

ApneaHypoxiaBradycardia

Condition Hierarchy (Ancestors)

Respiration DisordersRespiratory Tract DiseasesSigns and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and SymptomsArrhythmias, CardiacHeart DiseasesCardiovascular DiseasesPathologic Processes

Results Point of Contact

Title
Dr. Kalpashri Kesavan
Organization
University of California

Study Officials

  • Kalpashri Kesavan, MBBS

    University of California, Los Angeles

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
Open Label
Purpose
TREATMENT
Intervention Model
SEQUENTIAL
Model Details: In the same subject there were 2 periods: Arm 1. 'No intervention' period (no vibrations) - two 6 hour epochs - total of 12 hours of 'No intervention' Arm 2. Experimental period (with vibrations) - two 6 hour epochs - total of 12 hours of 'vibration intervention' In the same subjects cardiorespiratory parameters - heart rate, respiratory rate and oxygen saturation were compared during the experimental period (vibration) and druing the no intervention period (no vibration).
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Instructor

Study Record Dates

First Submitted

December 18, 2015

First Posted

December 29, 2015

Study Start

October 1, 2014

Primary Completion

August 1, 2015

Study Completion

February 1, 2016

Last Updated

May 9, 2017

Results First Posted

May 9, 2017

Record last verified: 2016-11

Data Sharing

IPD Sharing
Will share

Available online as supporting information: http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0157349#sec019

Locations